WOCKPHARMA.BOWOCKPHARMA.BOBSE
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank64
3Y CAGR+19.2%
5Y CAGR+62.6%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
+19.2%/yr
Annual compound
5Y CAGR
+62.6%/yr
Recent deceleration
Percentile
P64
Within normal range
vs 5Y Ago
11.4x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 11.86% | +143.2% |
| 2024 | 4.88% | +208.5% |
| 2023 | 1.58% | -77.4% |
| 2022 | 7.00% | +232.5% |
| 2021 | -5.28% | -606.7% |
| 2020 | 1.04% | +305.2% |
| 2019 | -0.51% | +67.4% |
| 2018 | -1.56% | -398.8% |
| 2017 | 0.52% | -95.4% |
| 2016 | 11.29% | - |